BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5419811)

  • 1. Thrombolytic agents and lysis of coronary artery thrombosis.
    Moschos CB; Burke WM; Lehan PH; Oldewurtel HA; Regan TJ
    Cardiovasc Res; 1970 Apr; 4(2):228-34. PubMed ID: 5419811
    [No Abstract]   [Full Text] [Related]  

  • 2. Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Wegner CD; Cox BF
    Thromb Haemost; 1999 Feb; 81(2):301-5. PubMed ID: 10064010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary thrombolytic therapy: state of the art.
    Marx M; Levin DC
    AJR Am J Roentgenol; 1986 Jul; 147(1):1-8. PubMed ID: 3521234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coronary thrombolysis in acute myocardial infarction. Initial experience with an intravenous thrombolytic agent].
    Martínez Ríos MA; Cárdenas M; Gil M; Iturbe I; Alarcón A; Soní J
    Arch Inst Cardiol Mex; 1984; 54(1):3-9. PubMed ID: 6372717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for acute coronary thrombosis.
    Simoons ML; Lubsen J; Serruys PW; Hugenholtz PG
    Eur Heart J; 1987 Sep; 8 Suppl F():78-87. PubMed ID: 3311764
    [No Abstract]   [Full Text] [Related]  

  • 6. Clot-selective coronary thrombolysis with tissue-type plasminogen activator.
    Bergmann SR; Fox KA; Ter-Pogossian MM; Sobel BE; Collen D
    Science; 1983 Jun; 220(4602):1181-3. PubMed ID: 6602378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (1).
    Laffel GL; Braunwald E
    N Engl J Med; 1984 Sep; 311(11):710-7. PubMed ID: 6382006
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-arterial thrombolytic therapy in peripheral vascular disease.
    Comerota AJ; Rubin RN; Tyson RR; White JV; Williams FF; Soulen RL; Sherry S
    Surg Gynecol Obstet; 1987 Jul; 165(1):1-8. PubMed ID: 3589918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of streptokinase on canine pulmonary emboli: local vs peripheral infusion.
    Johnson WC; Widrich WC; Patten DH; Asinari J; Nabseth DC
    J Surg Res; 1978 May; 24(5):366-73. PubMed ID: 651331
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
    Marder VJ
    Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    de Swart JB
    Drugs; 1987; 33 Suppl 3():279-81. PubMed ID: 3315607
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy].
    Belousov IuB
    Kardiologiia; 1986 Sep; 26(9):116-8. PubMed ID: 2946888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of intracoronary and intravenous methods of thrombolytic streptokinase therapy of patients with myocardial infarct].
    Markov VA; Varvarenko VI; Kun VI; Krylov AL; Stoliarov VA
    Kardiologiia; 1988 May; 28(5):20-3. PubMed ID: 3411854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction.
    Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW; Norry EC
    Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic therapy in acute myocardial infarction.
    Smucker DR; Burket MW
    Am Fam Physician; 1988 May; 37(5):265-74. PubMed ID: 3129924
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolysis for evolving myocardial infarction. Health and Public Policy Committee, American College of Physicians.
    Ann Intern Med; 1985 Sep; 103(3):463-9. PubMed ID: 3161441
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapy.
    Marder VJ; Kinsella PA; Brown MJ
    Drugs; 1987; 33 Suppl 3():237-41. PubMed ID: 3315601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New data on the action of intensain in coronary and myocardial insufficiency].
    Nitts R
    Kardiologiia; 1969 May; 9(5):23-7. PubMed ID: 4896560
    [No Abstract]   [Full Text] [Related]  

  • 20. ARE THROMBOLYTIC AGENTS MORE EFFECTIVE IF GIVEN NEAR THE THROMBUS?
    HUME M
    Lancet; 1964 Sep; 2(7358):500-1. PubMed ID: 14172918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.